Skip to contents

Joji Suzuki, MD
Associate Psychiatrist, Brigham and Women's Hospital
Assistant Professor of Psychiatry, Harvard Medical School

Brigham and Women's Hospital
Department of Psychiatry
75 Francis Street
Boston, MA 02115

Research Location: Peter Bent Brigham

Email: jsuzuki2@partners.org

Edit Profile


Education:
MD

Publications (Pulled from Harvard Catalyst Profiles):

1. Tolchin B, Baslet G, Suzuki J, Martino S, Blumenfeld H, Hirsch LJ, Altalib H, Dworetzky BA. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia. 2019 May; 60(5):986-995.

2. Sundaram S, Patil D, Suzuki J. The "White Powder Sign" for Substance Use in Hospitalized Patients. Psychosomatics. 2019 Apr 10.

3. Ward HB, Barnett BS, Suzuki J. Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report. Subst Abus. 2019 Mar 19; 1-6.

4. Suzuki J, Garayalde S, Dodoo M, Rodriguez C. Psychiatry residents' and fellows' confidence and knowledge in interpreting urine drug testing results related to opioids. Subst Abus. 2018; 39(4):518-521.

5. Weiner SG, Price CN, Atalay AJ, Harry EM, Pabo EA, Patel R, Suzuki J, Anderson S, Ashley SW, Kachalia A. A Health System-Wide Initiative to Decrease Opioid-Related Morbidity and Mortality. Jt Comm J Qual Patient Saf. 2019 01; 45(1):3-13.

6. Suzuki J, Johnson J, Montgomery M, Hayden M, Price C. Outpatient Parenteral Antimicrobial Therapy Among People Who Inject Drugs: A Review of the Literature. Open Forum Infect Dis. 2018 Sep; 5(9):ofy194.

7. Braun IM, Wright A, Peteet J, Meyer FL, Yuppa DP, Bolcic-Jankovic D, LeBlanc J, Chang Y, Yu L, Nayak MM, Tulsky JA, Suzuki J, Nabati L, Campbell EG. Medical Oncologists' Beliefs, Practices, and Knowledge Regarding Marijuana Used Therapeutically: A Nationally Representative Survey Study. J Clin Oncol. 2018 07 01; 36(19):1957-1962.

8. Friedmann PD, Suzuki J. More beds are not the answer: transforming detoxification units into medication induction centers to address the opioid epidemic. Addict Sci Clin Pract. 2017 11 15; 12(1):29.

9. Suzuki J, Zinser J, Issa M, Rodriguez C. Quantitative testing of buprenorphine and norbuprenorphine to identify urine sample spiking during office-based opioid treatment. Subst Abus. 2017 Oct-Dec; 38(4):504-507.

10. Twark C, Suzuki J. Fenethylline-Induced Psychosis, Fenethylline-Themed Paranoid Delusions, or Both? Psychosomatics. 2017 Sep - Oct; 58(5):561-564.